4
Changes in Ownership
LEXICON PHARMACEUTICALS, INC. Filed Acc 0001127602-25-005209
Options or other derivatives
- Chief Executive Officer acquired 3,774,480 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Exton Michael Chief Executive Officer | 2025-02-13 | Grant or award · Stock Option (Right to Buy) | +2,264,690 | 2,264,690 | D | ||
| Exton Michael Chief Executive Officer | 2025-02-13 | Grant or award · Restricted Stock Units | +1,509,790 | 1,509,790 | D | ||
Loading xslF345X05/form4.xml…